Trade Mark Journal No.2024/020 17 May 2024

UK00004045792 30 April 2024 (5)

Image for mark UK00004045792 SPYRE THERAPEUTICS
International priority date claimed: 2 November 2023 (United States of America) (98251421)
Class 5
Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders.

Aeglea BioTherapeutics, Inc.

Representative: Stobbs